Seth M. Pollack, MD

Sarcoma Program Director
Northwestern University Feinberg School of Medicine

Seth Pollack is the Steven T. Rosen Professor of Cancer Biology and the Sarcoma Program Director at the Northwestern University's Robert H. Lurie Cancer Center and Feinberg School of Medicine. His focus is on cancer immunotherapy for sarcoma with an emphasis on characterizing the sarcoma immune tumor microenvironment as well as cellular therapies.

Poster(s):

• (P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.

• (P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.

• (P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB

• (P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR

• (P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)

• (P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS